Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

BMP9 inhibits the bone metastasis of breast cancer cells by downregulating CCN2 (connective tissue growth factor, CTGF) expression.

Ren W, Sun X, Wang K, Feng H, Liu Y, Fei C, Wan S, Wang W, Luo J, Shi Q, Tang M, Zuo G, Weng Y, He T, Zhang Y.

Mol Biol Rep. 2014 Mar;41(3):1373-83. doi: 10.1007/s11033-013-2982-8. Epub 2014 Jan 12.

PMID:
24413988
2.

BMP9 inhibits the proliferation and invasiveness of breast cancer cells MDA-MB-231.

Wang K, Feng H, Ren W, Sun X, Luo J, Tang M, Zhou L, Weng Y, He TC, Zhang Y.

J Cancer Res Clin Oncol. 2011 Nov;137(11):1687-96. doi: 10.1007/s00432-011-1047-4. Epub 2011 Sep 3.

PMID:
21892652
3.

BMP9 regulates cross-talk between breast cancer cells and bone marrow-derived mesenchymal stem cells.

Wan S, Liu Y, Weng Y, Wang W, Ren W, Fei C, Chen Y, Zhang Z, Wang T, Wang J, Jiang Y, Zhou L, He T, Zhang Y.

Cell Oncol (Dordr). 2014 Oct;37(5):363-75. doi: 10.1007/s13402-014-0197-1. Epub 2014 Sep 11.

PMID:
25209393
4.

Bone morphogenetic protein 9 overexpression reduces osteosarcoma cell migration and invasion.

Lv Z, Yang D, Li J, Hu M, Luo M, Zhan X, Song P, Liu C, Bai H, Li B, Yang Y, Chen Y, Shi Q, Weng Y.

Mol Cells. 2013 Aug;36(2):119-26. doi: 10.1007/s10059-013-0043-8. Epub 2013 Jun 25.

5.

BMP9 inhibits proliferation and metastasis of HER2-positive SK-BR-3 breast cancer cells through ERK1/2 and PI3K/AKT pathways.

Ren W, Liu Y, Wan S, Fei C, Wang W, Chen Y, Zhang Z, Wang T, Wang J, Zhou L, Weng Y, He T, Zhang Y.

PLoS One. 2014 May 7;9(5):e96816. doi: 10.1371/journal.pone.0096816. eCollection 2014.

6.

Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer.

Shimo T, Kubota S, Yoshioka N, Ibaragi S, Isowa S, Eguchi T, Sasaki A, Takigawa M.

J Bone Miner Res. 2006 Jul;21(7):1045-59.

7.

Vascular endothelial growth inhibitor affects the invasion, apoptosis and vascularisation in breast cancer cell line MDA-MB-231.

Gao Y, Ge Z, Zhang Z, Bai Z, Ma X, Wang Y.

Chin Med J (Engl). 2014;127(10):1947-53.

PMID:
24824261
8.

Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway.

Katsuno Y, Hanyu A, Kanda H, Ishikawa Y, Akiyama F, Iwase T, Ogata E, Ehata S, Miyazono K, Imamura T.

Oncogene. 2008 Oct 23;27(49):6322-33. doi: 10.1038/onc.2008.232. Epub 2008 Jul 28.

PMID:
18663362
9.

DNALK2 inhibits the proliferation and invasiveness of breast cancer MDA-MB-231 cells through the Smad-dependent pathway.

Wang K, Sun X, Feng HL, Fei C, Zhang Y.

Oncol Rep. 2017 Feb;37(2):879-886. doi: 10.3892/or.2016.5343. Epub 2016 Dec 30.

PMID:
28075462
10.

Parathyroid hormone-related protein and bone metastases.

Guise TA.

Cancer. 1997 Oct 15;80(8 Suppl):1572-80. Review.

PMID:
9362424
11.

Connective tissue growth factor confers drug resistance in breast cancer through concomitant up-regulation of Bcl-xL and cIAP1.

Wang MY, Chen PS, Prakash E, Hsu HC, Huang HY, Lin MT, Chang KJ, Kuo ML.

Cancer Res. 2009 Apr 15;69(8):3482-91. doi: 10.1158/0008-5472.CAN-08-2524. Epub 2009 Apr 7.

12.

Bone morphogenetic protein 9 facilitates osteocarcinoma cell apoptosis and inhibits in vivo tumor growth.

Zhang J, Liang JH, Huang JG.

Genet Mol Res. 2016 Sep 16;15(3). doi: 10.4238/gmr.15038036.

PMID:
27706722
13.

Bone morphogenetic protein 9 regulates tumor growth of osteosarcoma cells through the Wnt/β-catenin pathway.

Lv Z, Wang C, Yuan T, Liu Y, Song T, Liu Y, Chen C, Yang M, Tang Z, Shi Q, Weng Y.

Oncol Rep. 2014 Feb;31(2):989-94. doi: 10.3892/or.2013.2931. Epub 2013 Dec 16.

PMID:
24337584
15.

In vivo inhibition of bone morphogenetic protein-2 on breast cancer cell growth.

Ye S, Park BH, Song KJ, Kim JR, Jang KY, Park HS, Bae JS, Brochmann EJ, Wang JC, Murray SS, Lee KB.

Spine (Phila Pa 1976). 2013 Feb 1;38(3):E143-50. doi: 10.1097/BRS.0b013e31827db4c6.

PMID:
23169070
16.

Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis.

Cai D, Cao J, Li Z, Zheng X, Yao Y, Li W, Yuan Z.

BMC Cancer. 2009 Apr 1;9:102. doi: 10.1186/1471-2407-9-102.

17.

Biological roles of human bone morphogenetic protein 9 in the bone microenvironment of human breast cancer MDA-MB-231 cells.

Wang W, Weng Y, Ren W, Zhang Z, Wang T, Wang J, Jiang Y, Chen Y, Zhou L, He T, Zhang Y.

Am J Transl Res. 2015 Sep 15;7(9):1660-74. eCollection 2015.

19.

Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer.

Jiang WG, Watkins G, Fodstad O, Douglas-Jones A, Mokbel K, Mansel RE.

Endocr Relat Cancer. 2004 Dec;11(4):781-91.

20.

Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer.

Guo D, Huang J, Gong J.

Mol Cell Biochem. 2012 Apr;363(1-2):179-90. doi: 10.1007/s11010-011-1170-1. Epub 2011 Dec 14.

PMID:
22167620

Supplemental Content

Support Center